Prevalence and management of anaemia in renal transplant recipients: Data from ten European centres

Nephron - Clinical Practice

Volumn 117, Issue 2, 2011, Pages

  Molnar, Miklos Zsolt ^a   Mucsi, Istvan ^a   Macdougall, Iain C ^b   Marsh, James E ^c   Yaqoob, Magdi ^d   Main, John ^e   Courtney, Aisling E ^f   Fogarty, Damien ^f   Mikhail, Ashraf ^g   Choukroun, Gabriel ^h   Short, Colin D ⁱ   Covic, Adrian ^j   Goldsmith, David J ^k  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c ST HELIER HOSPITAL   (United Kingdom)

^d Renal Unit   (United Kingdom)

^e JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^f BELFAST CITY HOSPITAL   (United Kingdom)

^g SWANSEA UNIVERSITY   (United Kingdom)

^h UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

ⁱ MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^j GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^k GUY S HOSPITAL   (United Kingdom)

more..

Author keywords

Anaemia; Chronic renal disease; Erythropoiesis stimulating agent therapy; Kidney transplantation

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; EUROPE; FEMALE; FERRITIN BLOOD LEVEL; GENDER; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEALTH CENTER; HEALTH SURVEY; HOSPITAL; HUMAN; IRON DEFICIENCY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL;

ANEMIA; COMORBIDITY; EUROPE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77955197828     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319660     Document Type: Article

References (33)

1. Molnar MZ, Czira M, Ambrus C, Szeifert L, Szentkiralyi A, Beko G, Rosivall L, Remport A, Novak M, Mucsi I: Anemia is associated with mortality in kidney-transplanted patients - a prospective cohort study. Am J Transplant 2007;7:818-824.
2. Chadban SJ, Baines L, Polkinghorne K, Jefferys A, Dogra S, Kanganas C, Irish A, Eris J, Walker R: Anemia after kidney transplantation is not completely explained by reduced kidney function. Am J Kidney Dis 2007;49:301-309.
3. Molnar MZ, Novak M, Ambrus C, Kovacs A, Pap J, Remport A, Szeifert L, Mucsi I: Anemia in kidney transplanted patients. Clin Transplant 2005;19:825-833.
4. Winkelmayer WC, Kewalramani R, Rutstein M, Gabardi S, Vonvisger T, Chandraker A: Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol 2004;15:1347-1352.
5. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F: Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003;3:835-845.
6. Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl WH, Sunder-Plassmann G: Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 2002;13:794-797.
7. Saito S, Fujiwara T, Sakagami K, Matsuno T, Tanaka N: Anemia following renal transplantation. Transplant Proc 1998;30:3025-3026.
8. Miles AM, Markell MS, Daskalakis P, Sumrani NB, Hong J, Sommer BG, Friedman EA: Anemia following renal transplantation: erythropoietin response and iron deficiency. Clin Transplant 1997;11:313-315.
9. Rebollo P, Baltar JM, Campistol JM, Ortega T, Ortega F: Quality of life of patients with chronic renal allograft rejection and anemia. J Nephrol 2004;17:531-536.
10. Djamali A, Becker YT, Simmons WD, Johnson CA, Premasathian N, Becker BN: Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients. Transplantation 2003;76:816-820.
11. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009;361:2019-2032.
12. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK: Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2004;44:94-111.
13. Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P: Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 2003;14:462-468.
14. Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J: Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 2002;13:1084-1090.
15. Winkelmayer WC, Lorenz M, Kramar R, Horl WH, Sunder-Plassmann G: Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant 2004;4:2075-2081.
16. Heinze G, Kainz A, Horl WH, Oberbauer R: Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ 2009;339: b4018.
17. Levey A, Greene T, Kusek J, Beck G, Group MS: A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000;11:155A.
18. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG: Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000;11(suppl 15): S1-S86.
19. National Kidney Foundation-K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47(suppl 3): S110-S116.
20. EBPG Expert Group on Renal Transplantation: European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 9.1. Haematological complications. Anaemia. Nephrol Dial Transplant 2002;17(suppl 4):48-49.
21. Target Guideline 5: Target haemoglobin concentration for the treatment of the anaemia of chronic renal failure. Nephrol Dial Transplant 1999;14(suppl 5):11-13.
22. Abutaleb N: Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components. Nephrol Dial Transplant 2007;22:2728-2729.
23. Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, Oehlert J, Salvatierra O, Alexander SR: Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 2002;40:1306-1318.
24. National Kidney Foundation-K/DOQI: IV. Clinical practice recommendations for anemia in chronic kidney disease in transplant recipients. Am J Kidney Dis 2006;47: S109-S116.
25. Yorgin PD, Scandling JD, Belson A, Sanchez J, Alexander SR, Andreoni KA: Late posttransplant anemia in adult renal transplant recipients. An under-recognized problem? Am J Transplant 2002;2:429-435.
26. Mix TC, Kazmi W, Khan S, Ruthazer R, Rohrer R, Pereira BJ, Kausz AT: Anemia: a continuing problem following kidney transplantation. Am J Transplant 2003;3:1426-1433.
27. Macdougall IC: What is the most appropriate strategy to monitor functional iron deficiency in the dialysed patient on rhEPO therapy? Merits of percentage hypochromic red cells as a marker of functional iron deficiency. Nephrol Dial Transplant 1998;13:847-849.
28. Karthikeyan V, Karpinski J, Nair RC, Knoll G: The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004;4:262-269.
29. Valderrabano F, Horl WH, Macdougall IC, Rossert J, Rutkowski B, Wauters JP: Pre-dialysis survey on anaemia management. Nephrol Dial Transplant 2003;18:89-100.
30. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D: Anemia, chronic renal disease and congestive heart failure - the cardiorenal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006;38:295-310.
31. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098.
32. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-2084.
33. Molnar MZ, Tabak AG, Czira ME, Rudas A, Ujszaszi A, Novak M, Remport A, Kivimäki M, Mucsi I: Erythropoietin-stimulating agent use, serum erythropoietin level and mortality in kidney transplant recipients. Submitted 2010.